作者：
Morishima,Y. [1]
;
Kawase,T. [2]
;
Malkki,M. [3]
;
Morishima,S. [4]
;
Spellman,S. [5]
;
Kashiwase,K. [6]
;
Kato,S. [7]
;
Cesbron,A. [8]
;
Tiercy,J.-M. [9]
;
Senitzer,D. [10]
;
Velardi,A. ;
Petersdorf,E.W.
作者单位：
Laboratoire d'Histocompatibilité, EFS Pays de la Loire, Nantes, France
[1]
City of Hope National Cancer Center, Duarte, CA, United States
[2]
Center for International Blood and Marrow Transplant Research, Minneapolis, MN, United States
[3]
LNRH/Transplantation Immunology Unit, University Hospital, Geneva, Switzerland
[4]
European Group for Blood and Marrow Transplantation, Perugia, Italy
[5]
Japan Marrow Donor Program, Tokyo, Japan, Japanese Red Cross Kanto-Koshinetsu Block Blood Center
[6]
Japan Marrow Donor Program, Tokyo, Japan, Department of Cell Transplantation and Regenerative
[7]
Japan Marrow Donor Program, Tokyo, Japan, Department of Hematology, Fujita Health University School
[8]
Japan Marrow Donor Program, Tokyo, Japan, Division of Epidemiology and Prevention, Aichi Cancer
[9]
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[10]
发布时间
2014-01-22
换一批
换一批
